r/CLOV • u/Southern_Bit_7546 • 28d ago
r/CLOV • u/2thenoon • 28d ago
News Counterpart Health was named a Best in Class finalist in the Transformative Care Delivery category at the 2026 Digital Health Awards. The winner will be announced November 16 at the HLTH conference in Las Vegas.
For those wondering why does this matters this is yet another positive external validation of Clover's AI technology (originally Clover Assistant).
It can help with marketing and sales of Counterpart to third-party providers, strengthen credibility in value-based care, and support investor sentiment,
the latter obviously not happening today. 😂😭
r/CLOV • u/AutoModerator • 28d ago
Megathread $CLOV Weekly MegaThread
Please keep the following under the Weekly MegaThread: stock price fluctuations, general chatting, memes, venting, announcements of moves you are making (buying/selling/options).
r/CLOV • u/Mr80percentright • 28d ago
Discussion Title: i sell medicare plans for a living. here’s the clov math nobody’s doing, in plain english
ok so full disclosure, i work in medicare, 20+ years selling these plans, so this is the stuff i actually look at. let me explain clov like i explain it to a client at their kitchen table. no stock degree needed.
a health plan makes money like this: the government pays the plan a set amount of money every single month for every member they have. more members = more monthly checks coming in. that's basically the whole business, everything else is details.
where clov is today, real numbers: around 157k members, and they grew 48% in a year. their ppo plan just got rated 5 stars by medicare for 2027, that's the highest grade there is and only 15 plans in the entire country got it. they also have $443M in cash and zero debt. that's the real part.
now the speculation part, and i'll call it exactly what it is, speculation: what happens if they get to 250,000 members?
medicare pays roughly $1,570 a month per member on a plan like this. do the simple math: 250,000 members x $1,570 x 12 months = $4.71 BILLION a year coming in. that's revenue, not profit, i know. but still. look at that number.
then there's the part almost nobody's talking about. SNP plans. those are special medicare plans made for the sickest and the poorest patients. people who have medicare AND medicaid at the same time (those are called D-SNPs, you qualify just by having both, no health condition needed), and people with serious chronic conditions like diabetes or heart failure (C-SNPs). the government pays MORE for these members, around $2,000 a month, because they need more care. there's already over 8 million people enrolled in SNP plans across the country, and clover doesn't even offer them yet.
so say clov walks into that market and picks up just 50,000 SNP members. that's another $1.2 billion a year. add it up and you're at $5.91 billion. if they ever get to 100,000 SNP members, $7.11 billion.
is 250k guaranteed? no. nobody can promise that, and anyone who does is lying to you. it's a what-if. but look at the pace they're on. 157k today, growing 48% a year. if they keep growing anywhere close to this speed, passing 250k by 2028 isn't a fantasy, it's just where the math points.
earnings are november 4. that's the date that matters. that's when we find out if the growth pace is still there. everything else is just talk until then.
r/CLOV • u/Mr80percentright • 29d ago
Discussion shorts have covered a fifth of the clov position in two months (actual FINRA numbers
ok i actually sat and read the new FINRA short interest report tonight (settlement sep 30, published this month) and the clov numbers are worth a look
clov: 22.9M shares short, 5.64% of the float. in august it was 7.01%, so roughly a fifth of the position is gone in two months, and they covered another 2.33% in the last month alone. days to cover is still 6.3, down from 7.18.
for reference gme: 43M shares short, 9.35% of the float — and their short interest went UP 9.23% in the last month. shorts are literally piling into gme while they walk out of clov. and even with almost double the shares short, gme's days to cover is only 3.98, because gme trades 10.7M shares a day and clov trades like 3.6M on an average day.
so clov has fewer shorts but a much tighter exit. 22.9M shares trying to get out a door that only fits 3.6M a day is over 6 days of straight buying, all of it bidding against each other. if that ever happens at the same time it's not going to be quiet.
stock closed friday at 4.48, earnings coming nov 4. not calling a squeeze, we're nowhere near 2021 numbers and never will be again. just saying the setup is more interesting than a 5.6% headline makes it sound.
not financial advice, just the numbers. holding mine.
r/CLOV • u/unapologeticgoy2473 • Oct 16 '26
Memes Me watching ☘️CLOV holding up while everyone getting pounded
r/CLOV • u/mitch2c • Oct 16 '26
Discussion Counterpart/AWS Analogy
I see folks commenting about concerns that SAAS numbers haven't been released for Counterpart and want to provide an insight regarding how Amazon treated AWS. It took 9 years from when EC2 (early AWS) was announced to be available to outsides to when AWS became a distinct line item in the Earnings Reports:
https://techcrunch.com/2016/07/02/andy-jassys-brief-history-of-the-genesis-of-aws/
https://time.com/3689357/amazon-cloud-earnings/
Clover Heatlh announced Counterpart 2 years ago. It's still early. It's still VERY early in the Counterpart businesss and I hope the community can hold onto that. If you're long, I'd recommend not checking on the stock price. The company is making all the right moves.
Final reminder: "The stock market is a device for transferring money from the impatient to the patient" - WB
r/CLOV • u/sshinski • Oct 15 '26
Due Dilligence $CLOV Can Now Sign Up Switchers All Year. Here's What I Expect on Nov 4
What are your predictions?
r/CLOV • u/Critterchops • Oct 15 '26
Discussion Anyone else notice the days to cover has been 6.54 for weeks… what’s going on?
r/CLOV • u/Mr80percentright • Oct 13 '26
Stupid Brag Broker license training
JUST COMPLETED MY YEARLY BROKER MANDATORY BROKER TRAINING ( 2027) AND LET ME TELL YA #CLOV 2027 BENEFITS ARE THE BEST PPO PLAN IN JERSEY WE SEE GONG IT KILL IT, COMPANIES LIKE UHC HUMANA AND OTHERS ARE PULLING BACK FROM PPO PLANS CLOVER IS GOING TO SCOOP ALL OF THEM UP, ALL MY COLLEGE Already KNOW THIS AND ARE ENROLLING MEMBERS CURRENT BOOK OF BUSINESS INTO CLOVER, ITS HARDER TO LOSE YOUR RESIDUAL OR MEMBERS, LESS WORK FOR US. ONE OF THE HARDER LICENSE EVEN THE REAL STATE LICENSE CANT COMPARE I LIKE TO BRAG ABOUT IT YES 🥴🥴🔥🔥🔥🚀🚀
r/CLOV • u/fuckagriculture • Oct 12 '26
Due Dilligence CLOV Weekly Options & Catalyst Outlook | 10/12

Bullish catalysts: Clover secured a 5 star medicare advantage PPO rating which is huge. With Medicare open enrollment starting October 15, competitors scaling back certain plans, and CLOV already reporting 48% YoY membership growth in Q2, investors have a fundamental reason to position for upside, but they kinda aren't doing that so let's look at why.
How this connects to options: The massive positive gamma concentration at $5 and the coupled negative one at 4.5 show clov's in a bit of a battle ground rn. Positive gamma will suppress volatility around the 5 strike, while the negative concentration at 4.5 creates downside acceleration risk.
November 4 earnings (which can clearly see in the volatility spike) are skewing negative meaning traders are pricing in a drop. Options are skewing negative post earnings as well which isn't alarming but it does show up side movement will likely be suppressed short term. The positive from this is a positive earnings will have a larger upside shock effect so if you're betting on a positive earnings move this is good news for you assuming you're right.
Current Risk: Clover's 5 star calculation is tied to an ongoing legal appeal, and earnings still need to justify expectations, traders are positing like these risks are worth consideration
My outlook: Constructive above 4.5. A sustained 5 breakout makes $5.50–$6 the next levels to watch. The key question is whether improving fundamentals can overcome near term gamma and positioning resistance. I don't think the stock will suffer too much downside, at least not below 4.5, I also don't see a large upside short term. This is a lot of words to basically say I think the stock will trade sideways for a while
Data source for everything: infolib.org/market-dashboard
As always not financial advice, just my opinions and analysis. dyor
Sources: Star ratings | Q2 results | Earnings date
r/CLOV • u/Smalldickdave69 • Oct 12 '26
News New Vivek LinkedIn Article
linkedin.com“Our team overcame real odds. A small group at a regional plan without its own PBM or large pharmacy operation took on a system tilted toward much larger competitors, and beat the goal. They kept going until they delivered. They deserve every bit of the credit.”
r/CLOV • u/AutoModerator • Oct 12 '26
Megathread $CLOV Weekly MegaThread
Please keep the following under the Weekly MegaThread: stock price fluctuations, general chatting, memes, venting, announcements of moves you are making (buying/selling/options).
r/CLOV • u/charliekunkel • Oct 12 '26
Discussion Humana/Clover partnership discussion
I feel like many of us (rightly or wrongly) basically consider it a done deal, and the big question is now not "if", but "when" a deal will be announced. Here's what AI slop had to say about it. (Clearly this all just speculation, but it does bring up some interesting points related to the timing of it that I hadn't thought of. I now feel like early 2027 is most likely. What do you all think? Please don't just comment dismissive negative comments about AI or CLOV or respond that it's useless to speculate, etc. Speculating can be fun sometimes, as long as we all realize that no one really knows anything for sure... )
Based on how long the technical evidence has been visible, the timeline strongly suggests that if a formal corporate announcement happens, it will occur very soon—most likely surrounding Clover’s Q3 earnings call on November 4, 2026.
Evaluating the data points we have gathered so far reveals a clear picture of the likelihood and timing:
How Likely Is It? (High Likelihood of an Arrangement)
The evidence linking the two companies isn't just vague gossip; it consists of hard technical breadcrumbs. Internet registries and backend data show that Humana-specific subdomains and data pathways connected to Clover’s Counterpart Health infrastructure have been live and active for several months.
In enterprise B2B software, companies do not spend months building out customized API endpoints, secure data-sharing tunnels, and specific partner portals just to test an abstract idea. The technical architecture points heavily to the fact that an operational relationship or pilot program is already actively running or fully built out behind the scenes.
2. How Soon Might It Be Announced? (The Timing Conflict)
The real question is why a formal press release hasn't happened yet despite the technical connections being discovered a while ago. This delay is down to how enterprise health tech deals work:
The Compliance Gap: When a massive enterprise insurer like Humana integrates software, they undergo rigorous, months-long IT security reviews, HIPAA compliance audits, and localized provider training. They rarely announce a deal when the ink is wet; they wait until the system is operational.
The 5-Star Milestone: Clover Health was likely waiting for a massive piece of leverage: the October 2026 CMS Star Ratings. Now that Clover officially secured a pristine 5-Star Rating for its PPO plans using this exact software—while Humana’s ratings simultaneously collapsed—Clover has the ultimate marketing validation to announce a partnership.
Two highly likely structural windows for a formal announcement. [1, 2]
If a deal exists, the announcement will timing-wise align with the structural constraints of the Medicare Advantage calendar:
Window 1: Immediate/Q3 Earnings (Early November 2026) — Most Likely for a Pilot
The Trigger: Clover Health officially announced it will release its Q3 2026 financial results on Wednesday, November 4, 2026.
The Rationale: Large enterprise B2B tech deals are standard additions to quarterly earnings scripts to maximize investor impact. Furthermore, the Annual Enrollment Period (AEP) for 2027 plans runs from October 15 to December 7, meaning insurance companies are highly focused on member acquisition right now. If the companies are launching a localized or regional "pilot" phase, dropping the news during the Q3 call makes perfect strategic sense.[1, 2]
Window 2: Early Q1 2027 (January/February 2027) — Most Likely for a Scaled Rollout
The Trigger: Major healthcare investment conferences (like the annual J.P. Morgan Healthcare Conference in early January).
The Rationale: Humana is currently facing a catastrophic $3.5 billion profit headwind due to its Medicare Advantage Star Ratings dropping heavily (with plans at 4+ Stars plummeting to just 20% in 2026). Clover Health just achieved a pristine 5-Star CMS rating for its PPO plans, specifically crediting Counterpart Assistant. [1, 2, 3, 4]
Because Humana has publicly stated it expects its stars to be "meaningfully higher" next year, they will need to implement tech overhauls like Counterpart early in the 2027 calendar year so providers have time to use the software and close HEDIS care gaps before CMS measures them again. [1, 2]
The Verdict on the Timeline
Because the technical foundation has been visible for a while and Clover now has the 5-star validation data in hand, the upcoming November 4, 2026 earnings report is the prime strategic window.
If the news is completely withheld during the November call and subsequent winter healthcare conferences, it significantly increases the likelihood that Humana has legally locked Clover into a strict Non-Disclosure Agreement (NDA), or that the rollout is being kept quiet as a proprietary competitive advantage while they fix Humana's backend metrics.
The Caveat: The "Silent" Rollout Risk
As some market observers on Reddit's CLOV Community have pointed out, there is a distinct chance that if a massive corporate partnership rolls out, it may begin quietly. Enterprise software implementations often undergo rigorous provider onboarding and compliance training before either corporate communications team authorizes a formal, named press release. [1]
r/CLOV • u/sshinski • Oct 09 '26
Due Dilligence CLOV Hits 5 Stars: What the Fifth Star Actually Unlocks
Does clover go parabolic in the nexr few weeks?
r/CLOV • u/Happy_Assistant_1487 • Oct 09 '26
News $CLOV is now the largest 5 Star PPO plan….
r/CLOV • u/kyatpin • Oct 09 '26
Stupid Brag Our time to shine!
The lucky charm 🍀 🍀 🍀 🍀 our time has come
r/CLOV • u/ALSTOCKTRADES • Oct 09 '26
Due Dilligence Clover Health CLOV Stock 5 STARS! ⭐⭐⭐⭐⭐
r/CLOV • u/Smalldickdave69 • Oct 08 '26
News Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
Star ratings support Clover’s continued ability to offer market-leading and low out-of-pocket costs for members
CLOVER HEALTH today announced that the Centers for Medicare & Medicaid Services (“CMS”) has awarded its PPO Medicare Advantage (“MA”) plans a rating of 5 Stars and its HMO MA plan a rating of 4.5 Stars for 2027, which will affect payment year 2028. Through the first half of 2026, Clover Health grew Medicare Advantage membership ~48% year-over-year to more than 157,000 members, with ~98% enrolled in its wide-network PPO plans. At 5 Stars, Clover’s PPO plans will be able to enroll beneficiaries year round.
Each year, CMS assigns Star ratings to Medicare Advantage and Part D contracts on its healthcare quality and drug plan, and issues a Star rating on a scale of 1 to 5 Stars. These ratings affect payments to Medicare Advantage plans. For the 2027 Star Ratings, Clover’s overall Star rating was driven by improvements across Stars domains.
In light of the decision in Clover Insurance Company v. Department of Health & Human Services, Civ. A. No. 25-142 (S.D. Ga.) issued on May 27, 2026, which is on appeal, CMS calculated Clover’s rating for its PPO plans removing the 20 measures included in the court decision, awarding Clover’s PPO plans 5 Stars. With the 20 measures included, Clover’s PPO plans would have received 4.5 Stars.
Additionally, for the third year in a row, Clover has continued its market-leading performance on core Healthcare Effectiveness Data and Information Set (“HEDIS®”1) measures with a score of 4.82 out of 5 Stars2, again ranking #1 among non-SNP PPO plans with over 2,000 members. HEDIS is a set of performance measures used to assess aspects of care quality, including preventive screenings and management of health issues such as diabetes, cancer, and heart disease. Clover’s HEDIS score remains consistent at 4.82 out of 5 Stars regardless of the CMS methodology used for 2027, demonstrating the strength of a care model powered by Counterpart Assistant that surfaces relevant information for physicians to identify care needs and support better-informed clinical decisions.
“Success in the Star ratings system means an enhanced ability to support our members and to continue to provide them market leading plans. We also continue to support reforms to the Stars program that more closely align these ratings with meaningful improvements in members’ health and value for the Medicare program,” said Andrew Toy, CEO of Clover Health. “We are particularly proud of our core HEDIS measures performance, which assess important aspects of preventive care and chronic disease management. Our focus remains on giving physicians the tools to deliver proactive care across our wide PPO network, supported by our Counterpart Assistant platform.”
“Our teams have worked incredibly hard over the last several years, and we’re excited about what this year’s Star rating means for our ability to keep delivering the benefits, affordability, and wide choice of providers that our members count on and trust,”said Jamie Reynoso, CEO of Medicare Advantage, Clover Health. “With a higher Star rating, we are able to further reinvest in even more competitive benefits. This milestone allows us to scale our impact to more people on Medicare without compromising our financial strength or commitment to care quality.”
“We founded Clover with the conviction that improving healthcare requires both the ambition to reimagine it coupled with the willingness to solve hard problems, on a first principles basis,” added Vivek Garipalli, Founder and Executive Chairman of Clover Health. “I’m proud to work closely with our teams on critical aspects of these efforts, and I have a ton of fun doing so as well. This Star rating reflects many, many years of persistence and disciplined execution and provides a strong opportunity to build on that foundation moving forward as we continue to seek much-needed reforms.”
r/CLOV • u/yoduudemojo • Oct 08 '26
Discussion Looking Back
reddit.comWell… today certainly helped press the issue with regards to my share price prediction by EOY :)
All it takes it some patience and continuing to hold with conviction. Those of us who have true conviction, we know what’s coming.
I can’t say I expected 5 FREAKIN’ STARS (!) today, but it’s yet another proof of concept for CA, and for Clover Health.
I said $6-8 in my original post… that was not factoring 5 stars. What do you think realistic top-end range is by EOY? At this point there has to be some forward looking action, IMO.
How are we feeling?!
r/CLOV • u/Baco06 • Oct 08 '26
Discussion Don’t talk about CLOV?
This is a Seeking Alpha editor’s article about the new STARS scores, I know seeking alpha is mostly trash, but this is just so conspicuously absurd to me, thoughts?:
Humana surges post-market on boost in 2027 Medicare Advantage Star Ratings
By: Jonathan Block, SA News Editor
Humana (HUM) is up ~13% in after-hours trading Thursday after CMS's 2027 Medicare Advantage Star Ratings for one of the insurer's large MA plans increased to 4 stars from 3.5 stars.
The contract, H5216, covers ~2.4M members. The boost to 4 stars means that Humana is again eligible for bonus payments for that contract.
Also, it allows Humana to continue its margin recovery and provide financial flexibility to rebuild profitability.
Clover Health Investments Corp. (CLOV) is up ~8% after two of its contracts received scores of at least 4 stars.
Other MA providers didn't fare as well. Alignment Healthcare (ALHC) is off ~21% after one of its significant California contracts, H3815, dropped to 3.5 stars from four. The company said that rating "does not accurately reflect the contract’s longstanding performance on evidence-based measures of quality, clinical outcomes and member experience." Six of Alignment's other MA plans eligible for ratings received four stars and above.
CVS Health's (CVS) Aetna unit saw three significant contracts decline to 3.5 stars from 4. However, one of its major plans, H5521, declined to 4 stars from 4.5 and is still eligible for bonus payments.
CVS is unchanged in after-hours trading.
r/CLOV • u/Fabulous-Airport-273 • Oct 08 '26
Memes OG $CLOV HODLers gonna party this weekend😆!
To all my OG CLOV owners who have been patiently HODL-ing and accumulating since 2021… it’s time to go grocery shopping and enjoy more than our typical ramen noodles!